科瑞斯塔生物科技 KRYS
$300.88 +$0.63 (+0.21%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $300.88 0.00%
开盘$298.31
昨收$300.25
当日区间$297.52 – $305.60
成交量234.2K
市值$8.92B
市盈率（TTM）40.9
股息率–
KRYS 相关新闻
匹配 Krystal Biotech 或代码 KRYS 的头条新闻，按最新排序。
- Krystal Biotech(KRYS.US) 10% Shareholder Sells US$8.98 Million in Common Stock
- Goldman Sachs Maintains Krystal Biotech(KRYS.US) With Buy Rating, Raises Target Price to $441 正面
- BofA Securities Maintains Krystal Biotech(KRYS.US) With Buy Rating, Raises Target Price to $400 正面
- Citi Maintains Krystal Biotech(KRYS.US) With Buy Rating, Raises Target Price to $386 正面
- BofA Securities Maintains Krystal Biotech(KRYS.US) With Buy Rating, Cuts Target Price to $392 负面
- H.C. Wainwright Maintains Krystal Biotech(KRYS.US) With Buy Rating, Maintains Target Price $361
- TD Cowen Maintains Krystal Biotech(KRYS.US) With Buy Rating, Maintains Target Price $403
- William Blair Maintains Krystal Biotech(KRYS.US) With Buy Rating
- RBC Capital Initiates Krystal Biotech(KRYS.US) With Buy Rating, Announces Target Price $400
- Krystal Biotech(KRYS.US) Director Sells US$8.23 Million in Common Stock
- Wolfe Research Maintains Krystal Biotech(KRYS.US) With Hold Rating
- BofA Securities Maintains Krystal Biotech(KRYS.US) With Buy Rating, Raises Target Price to $396 正面
- Jefferies Maintains Krystal Biotech(KRYS.US) With Buy Rating, Raises Target Price to $474 正面
- TD Cowen Maintains Krystal Biotech(KRYS.US) With Buy Rating, Raises Target Price to $403 正面
- H.C. Wainwright Maintains Krystal Biotech(KRYS.US) With Buy Rating, Raises Target Price to $361 正面
暂无评论——快来第一个聊聊 KRYS。
登录后参与讨论。